Translation of quantitative MRI analysis tools for clinical neuroradiology application

Quantification of imaging features can assist radiologists by reducing subjectivity, aiding detection of subtle pathology, and increasing reporting consistency. Translation of quantitative image analysis techniques to clinical use is currently uncommon and challenging. This thesis explores translation of quantitative imaging support tools for clinical neuroradiology use. I have proposed a translational framework for development of quantitative imaging tools, using dementia as an exemplar application. This framework emphasises the importance of clinical validation, which is not currently prioritised. Aspects of the framework were then applied to four disease areas: hippocampal sclerosis (HS) as a cause of epilepsy; dementia; multiple sclerosis (MS) and gliomas. A clinical validation study for an HS quantitative report showed that when image interpreters used the report, they were more accurate and confident in their assessments, particularly for challenging bilateral cases. A similar clinical validation study for a dementia reporting tool found improved sensitivity for all image interpreters and increased assessment accuracy for consultant radiologists. These studies indicated benefits from quantitative reports that contextualise a patient’s results with appropriate normative reference data. For MS, I addressed a technical translational challenge by applying lesion and brain quantification tools to standard clinical image acquisitions which do not include a conventional T1-weighted sequence. Results were consistent with those from conventional sequence inputs and therefore I pursued this concept to establish a clinically applicable normative reference dataset for development of a quantitative reporting tool for clinical use. I focused on current radiology reporting of gliomas to establish which features are commonly missed and may be important for clinical management decisions. This informs both the potential utility of a quantitative report for gliomas and its design and content. I have identified numerous translational challenges for quantitative reporting and explored aspects of how to address these for several applications across clinical neuroradiology

Radiomic data mining and machine learning on preoperative pituitary adenoma MRI

Pituitary adenomas are among the most frequent intracranial tumors, accounting for the majority of sellar/suprasellar masses in adults. MRI is the preferred imaging modality for detecting pituitary adenomas. Radiomics represents the conversion of digital medical images into mineable high-dimensional data. This process is motivated by the concept that biomedical images contain information that reflects underlying pathophysiology and that these relationships can be revealed via quantitative image analyses. The aim of this thesis is to apply machine learning algorithms on parameters obtained by texture analysis on MRI images in order to distinguish functional from non-functional pituitary macroadenomas, to predict their ki-67 proliferation index class, and to predict pituitary macroadenoma surgical consistency prior to an endoscopic endonasal procedure

Advancements in Neuroradiology via Artificial Intelligence and Machine Learning

Neuroradiology is significantly showing the broad impact in field of Artificial intelligence research and also in Machine learning. Neuro-radiology includes methods such as neuro-imaging which simply diagnose and characterize disorders of the CNS and PNS. Artificial Intelligence (AI) is one of the main attribute in the field of computer science generally focusing on creating "algorithms" which can be used to solve any arbitrary desired problem. AI has several applications in the field of Neuroradiolody and one of the most common and influencing application is machine learning. Machine learning is a data science approach that allows computers to learn without being programmed with specific rules. Some of the factors which shows neuroradiological impact on AI research are; (a) neuroimaging comprising rich, multicontrast, multidimensional, and multimodality data which fit themselves well to machine learning tasks; (b) consideration of well-established neuroimaging public datasets of various neural diseases such as Alzheimer disease, Parkinson disease, tumors, different forms of sclerosis etc. (c) quantitative neuroimaging research history which proves clinical practices. Another major application is Deep learning which is useful in management of information content of digital pictures that a human reader can only identify and use partially. Except this various limitations also come in the picture such as adoption in neuroradiology practice etc. Till now several research has been done which connects the concepts of Neuroradiology and Artificial intelligence and yet more to be done so as to overcome the limitations of AI in Neuroradiology

TEXTURAL CLASSIFICATION OF MULTIPLE SCLEROSISLESIONS IN MULTIMODAL MRI VOLUMES

Background and objectives:Multiple Sclerosis is a common relapsing demyelinating diseasecausing the significant degradation of cognitive and motor skills and contributes towards areduced life expectancy of 5 to 10 years. The identification of Multiple Sclerosis Lesionsat early stages of a patient’s life can play a significant role in the diagnosis, treatment andprognosis for that individual. In recent years the process of disease detection has been aidedthrough the implementation of radiomic pipelines for texture extraction and classificationutilising Computer Vision and Machine Learning techniques. Eight Multiple Sclerosis Patient datasets have been supplied, each containing one standardclinical T2 MRI sequence and four diffusion-weighted sequences (T2, FA, ADC, AD, RD).This work proposes a Multimodal Multiple Sclerosis Lesion segmentation methodology util-ising supervised texture analysis, feature selection and classification. Three Machine Learningmodels were applied to Multimodal MRI data and tested using unseen patient datasets to eval-uate the classification performance of various extracted features, feature selection algorithmsand classifiers to MRI volumes uncommonly applied to MS Lesion detection. Method: First Order Statistics, Haralick Texture Features, Gray-Level Run-Lengths, His-togram of Oriented Gradients and Local Binary Patterns were extracted from MRI volumeswhich were minimally pre-processed using a skull stripping and background removal algorithm.mRMR and LASSO feature selection algorithms were applied to identify a subset of rankingsfor use in Machine Learning using Support Vector Machine, Random Forests and ExtremeLearning Machine classification. Results: ELM achieved a top slice classification accuracy of 85% while SVM achieved 79%and RF 78%. It was found that combining information from all MRI sequences increased theclassification performance when analysing unseen T2 scans in almost all cases. LASSO andmRMR feature selection methods failed to increase accuracy, and the highest-scoring groupof features were Haralick Texture Features, derived from Grey-Level Co-occurrence matrices

Accuracy of deep learning to differentiate the histopathological grading of meningiomas on MR images: a preliminary study

Background: Grading of meningiomas is important in the choice of the most effective treatment for each patient. Purpose: To determine the diagnostic accuracy of a deep convolutional neural network (DCNN) in the differentiation of the histopathological grading of meningiomas from MR images. Study Type: Retrospective. Population: In all, 117 meningioma-affected patients, 79 World Health Organization [WHO] Grade I, 32 WHO Grade II, and 6 WHO Grade III. Field Strength/Sequence: 1.5 T, 3.0 T postcontrast enhanced T1 W (PCT1W), apparent diffusion coefficient (ADC) maps (b values of 0, 500, and 1000 s/mm2). Assessment: WHO Grade II and WHO Grade III meningiomas were considered a single category. The diagnostic accuracy of the pretrained Inception-V3 and AlexNet DCNNs was tested on ADC maps and PCT1W images separately. Receiver operating characteristic curves (ROC) and area under the curve (AUC) were used to asses DCNN performance. Statistical Test: Leave-one-out cross-validation. Results: The application of the Inception-V3 DCNN on ADC maps provided the best diagnostic accuracy results, with an AUC of 0.94 (95% confidence interval [CI], 0.88\u20130.98). Remarkably, only 1/38 WHO Grade II\u2013III and 7/79 WHO Grade I lesions were misclassified by this model. The application of AlexNet on ADC maps had a low discriminating accuracy, with an AUC of 0.68 (95% CI, 0.59\u20130.76) and a high misclassification rate on both WHO Grade I and WHO Grade II\u2013III cases. The discriminating accuracy of both DCNNs on postcontrast T1W images was low, with Inception-V3 displaying an AUC of 0.68 (95% CI, 0.59\u20130.76) and AlexNet displaying an AUC of 0.55 (95% CI, 0.45\u20130.64). Data Conclusion: DCNNs can accurately discriminate between benign and atypical/anaplastic meningiomas from ADC maps but not from PCT1W images. Level of evidence: 2 Technical Efficacy: Stage

Simultaneous lesion and neuroanatomy segmentation in Multiple Sclerosis using deep neural networks

Segmentation of both white matter lesions and deep grey matter structures is an important task in the quantification of magnetic resonance imaging in multiple sclerosis. Typically these tasks are performed separately: in this paper we present a single segmentation solution based on convolutional neural networks (CNNs) for providing fast, reliable segmentations of multimodal magnetic resonance images into lesion classes and normal-appearing grey- and white-matter structures. We show substantial, statistically significant improvements in both Dice coefficient and in lesion-wise specificity and sensitivity, compared to previous approaches, and agreement with individual human raters in the range of human inter-rater variability. The method is trained on data gathered from a single centre: nonetheless, it performs well on data from centres, scanners and field-strengths not represented in the training dataset. A retrospective study found that the classifier successfully identified lesions missed by the human raters. Lesion labels were provided by human raters, while weak labels for other brain structures (including CSF, cortical grey matter, cortical white matter, cerebellum, amygdala, hippocampus, subcortical GM structures and choroid plexus) were provided by Freesurfer 5.3. The segmentations of these structures compared well, not only with Freesurfer 5.3, but also with FSL-First and Freesurfer 6.0

Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis-a systematic review

Developments in neuroradiological MRI analysis offer promise in enhancing objectivity and consistency in dementia diagnosis through the use of quantitative volumetric reporting tools (QReports). Translation into clinical settings should follow a structured framework of development, including technical and clinical validation steps. However, published technical and clinical validation of the available commercial/proprietary tools is not always easy to find and pathways for successful integration into the clinical workflow are varied. The quantitative neuroradiology initiative (QNI) framework highlights six necessary steps for the development, validation and integration of quantitative tools in the clinic. In this paper, we reviewed the published evidence regarding regulatory-approved QReports for use in the memory clinic and to what extent this evidence fulfils the steps of the QNI framework. We summarize unbiased technical details of available products in order to increase the transparency of evidence and present the range of reporting tools on the market. Our intention is to assist neuroradiologists in making informed decisions regarding the adoption of these methods in the clinic. For the 17 products identified, 11 companies have published some form of technical validation on their methods, but only 4 have published clinical validation of their QReports in a dementia population. Upon systematically reviewing the published evidence for regulatory-approved QReports in dementia, we concluded that there is a significant evidence gap in the literature regarding clinical validation, workflow integration and in-use evaluation of these tools in dementia MRI diagnosis

A novel CT‑based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions

Purpose Automated analysis of neuroimaging data is commonly based on magnetic resonance imaging (MRI), but sometimes the availability is limited or a patient might have contradictions to MRI. Therefore, automated analyses of computed tomography (CT) images would be beneficial. Methods We developed an automated method to evaluate medial temporal lobe atrophy (MTA), global cortical atrophy (GCA), and the severity of white matter lesions (WMLs) from a CT scan and compared the results to those obtained from MRI in a cohort of 214 subjects gathered from Kuopio and Helsinki University Hospital registers from 2005 - 2016. Results The correlation coefficients of computational measures between CT and MRI were 0.9 (MTA), 0.82 (GCA), and 0.86 (Fazekas). CT-based measures were identical to MRI-based measures in 60% (MTA), 62% (GCA) and 60% (Fazekas) of cases when the measures were rounded to the nearest full grade variable. However, the difference in measures was 1 or less in 97-98% of cases. Similar results were obtained for cortical atrophy ratings, especially in the frontal and temporal lobes, when assessing the brain lobes separately. Bland-Altman plots and weighted kappa values demonstrated high agreement regarding measures based on CT and MRI. Conclusions MTA, GCA, and Fazekas grades can also be assessed reliably from a CT scan with our method. Even though the measures obtained with the different imaging modalities were not identical in a relatively extensive cohort, the differences were minor. This expands the possibility of using this automated analysis method when MRI is inaccessible or contraindicated.Peer reviewe

Complex Grey Matter Structure Segmentation in Brains via Deep Learning: Example of the Claustrum

Segmentationand parcellation of the brain has been widely performed on brain MRI using atlas-based methods. However, segmentation of the claustrum, a thin and sheet-like structure between insular cortex and putamen has not been amenable to automatized segmentation, thus limiting its investigation in larger imaging cohorts. Recently, deep-learning based approaches have been introduced for automated segmentation of brain structures, yielding great potential to overcome preexisting limitations. In the following, we present a multi-view deep-learning based approach to segment the claustrum in T1-weighted MRI scans. We trained and evaluated the proposed method on 181 manual bilateral claustrum annotations by an expert neuroradiologist serving as reference standard. Cross-validation experiments yielded median volumetric similarity, robust Hausdor? distance and Dice score of 93.3%, 1.41mm and 71.8% respectively which represents equal or superior segmentation performance compared to human intra-rater reliability. Leave-one-scanner-out evaluation showed good transfer-ability of the algorithm to images from unseen scanners, however at slightly inferior performance. Furthermore, we found that AI-based claustrum segmentation benefits from multi-view information and requires sample sizes of around 75 MRI scans in the training set. In conclusion, the developed algorithm has large potential in independent study cohorts and to facilitate MRI-based research of the human claustrum through automated segmentation. The software and models of our method are made publicly available.Comment: submitted to a journa

ISLES 2022: A multi-center magnetic resonance imaging stroke lesion segmentation dataset.

Magnetic resonance imaging (MRI) is an important imaging modality in stroke. Computer based automated medical image processing is increasingly finding its way into clinical routine. The Ischemic Stroke Lesion Segmentation (ISLES) challenge is a continuous effort to develop and identify benchmark methods for acute and sub-acute ischemic stroke lesion segmentation. Here we introduce an expert-annotated, multicenter MRI dataset for segmentation of acute to subacute stroke lesions ( https://doi.org/10.5281/zenodo.7153326 ). This dataset comprises 400 multi-vendor MRI cases with high variability in stroke lesion size, quantity and location. It is split into a training dataset of n = 250 and a test dataset of n = 150. All training data is publicly available. The test dataset will be used for model validation only and will not be released to the public. This dataset serves as the foundation of the ISLES 2022 challenge ( https://www.isles-challenge.org/ ) with the goal of finding algorithmic methods to enable the development and benchmarking of automatic, robust and accurate segmentation methods for ischemic stroke